🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial examines sustained oral fiber supplementation for patie...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-22
Trial ID
NCT04829136
Allogeneic Haemopoietic Stem Cell Transplant (Allo-HSCT) is a potentially c...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2024-05-24
Trial ID
NCT06704243
Treatments Being Tested
This research study is evaluating the reactivation of BK virus in patients ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2018-07-30
Trial ID
NCT03532971
Treatments Being Tested
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
In this study, treosulfan is evaluated for conditioning in allogenic stem c...
Status
Unknown
Location
Hôpital Edouard Herriot
Start Date
2005-02
Trial ID
NCT00129155
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2007-03
Trial ID
NCT00623935
Treatments Being Tested
Patients enrolled on this study will have received a stem cell transplant. ...
Status
Withdrawn
Location
Texas Childrens Hospital
Start Date
2018-03-01
Trial ID
NCT02313844
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested